The Ganesha Lab is an accelerator for biotechnology-based startups in Latin America. On November 9 and 10, they held the BioHunt Summit in Miami, a gathering of investors and startups featuring 25 biotechnology companies that had been previously selected from among more than 250 applicants.

The summit was attended by venture capital funds from the region (Chile, Argentina, Colombia, Mexico, and the United States), angel investors—primarily from the state of Florida—as well as key specialized partners such as the Massachusetts Life Science Center and Thermo Fisher Scientific, among others.

There were four interesting panel discussions focusing on the megatrends that these startups are seeking to address:

1. Emerging Threats
2. Food Scarcity
3. Aging Population and Chronic Diseases
4. Healthcare Access

One-on-one meetings were held with the aim of bringing entrepreneurs and investors together to learn more details and delve deeper into specific aspects of potential investments in the respective startups.

The goal of these meetings is to facilitate impact investments in startups seeking to bring about change through biotechnology, with projects ranging from the early detection of diseases to solutions for halting inflammation in cancer cells,as well as chromosome studies for the early detection of pathologies and the design of templates using artificial intelligence algorithms based on biomechanical studies.

Representing FYNSA, Cristián Donoso was in attendance to get to know the various entrepreneurs and their projects better and to seek out new opportunities for our investors.